Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects.
Archon Biosciences is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs).
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.
Radiant is a biotechnology company developing the next generation of multi-specificity.
Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.
5Metis is a new pure-play discovery company for crop health.
Umaro Foods uses green chemistry to unlock value-added ingredients and chemicals from seaweed
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Early stage biotechnology company
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Alexandria Venture Investments has invested in 187 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Judo Bio received $75.0M in a Series A round. Alexandria Venture Investments's total known invested capital is $7.0B.
Alexandria Venture Investments's average investment size is $41.5M across its portfolio of 187 companies.
Recent Alexandria Venture Investments portfolio additions include Jupiter BioVentures, Archon Biosciences, Passkey, Judo Bio, 858 Therapeutics. These companies were founded in 2020 or later.